Biologics and small molecules for perianal Crohn's disease: a systematic review and meta-analyses of randomized placebo-controlled trials. [PDF]
Yuan Y +9 more
europepmc +1 more source
Cost-Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan. [PDF]
Igarashi A +6 more
europepmc +1 more source
Comparative Effectiveness of Four Biologics for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. [PDF]
Abdullah A, Polus L.
europepmc +1 more source
Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab. [PDF]
Al Hosani M +12 more
europepmc +1 more source
Efficacy of Risankizumab in Moderate to Severe Psoriasis Considering Body Mass Index: A Scoping Review. [PDF]
Sarmiento K +6 more
europepmc +1 more source
Interleukin-23 Inhibitors in Inflammatory Bowel Disease. [PDF]
Puca P +8 more
europepmc +1 more source
Highlights of the 2026 European Crohn's and Colitis Conference: redefining the IBD care continuum. [PDF]
Al-Hindawi A +4 more
europepmc +1 more source
Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease. [PDF]
Ooi CJ +34 more
europepmc +1 more source
Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis. [PDF]
Crowley J +11 more
europepmc +1 more source

